Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIIb randomized study of rituximab added to bendamustine or chlorambucil in chronic lymphocytic leukemia
2009-012072-28Phase 3Completed
- Sponsor
- Roche
- Start
- Oct 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) comparing rituximab + bendamustine with rituximab + chlorambucil (2 arms). Primary endpoint: Confirmed complete response rate after 6 cycles. Started Oct 2009; status: completed.
02
Drugs
rituximabbendamustinechlorambucil
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on 2009-012072-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012072-28.